The Situation
Sun Pharma provides high-quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries of the world and has developed the first and only approved cyclosporine ophthalmic solution (CsA) product that incorporates a nanomicellar technology. The novel new compound is faster acting and more comfortable when administered providing an effective alternative to the current medications. Brandsymbol was tasked with the development of a world-class proprietary brand name that propels this incredibly unique, first-of-its-kind product towards the success worthy of innovative stature.
